Axon Enterprise (NASDAQ:AXON) Announces Earnings Results

Axon Enterprise (NASDAQ:AXON) issued its earnings results on Monday. The biotechnology company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.20, Briefing.com reports. The business had revenue of $460.74 million for the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The business’s quarterly revenue was up 34.3% on a year-over-year basis. During the same period last year, the company posted $0.51 EPS. Axon Enterprise updated its FY 2024 guidance to EPS.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $311.86 on Thursday. The stock has a market capitalization of $23.53 billion, a P/E ratio of 135.59 and a beta of 0.91. The firm’s 50-day moving average price is $310.82 and its two-hundred day moving average price is $267.44. Axon Enterprise has a 52-week low of $175.37 and a 52-week high of $329.87. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Robert W. Baird increased their price objective on shares of Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research report on Thursday, February 22nd. StockNews.com lowered Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. JPMorgan Chase & Co. raised their target price on Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Finally, TheStreet downgraded shares of Axon Enterprise from a “b” rating to a “c+” rating in a research note on Tuesday, February 27th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $333.08.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.